dapsone has been researched along with Methemoglobinemia in 187 studies
Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"V methylene blue therapy causes significant decline in MetHb level and is more effective in treatment of methemoglobinemia as compared to intermittent regimen." | 9.13 | Dapsone induced methemoglobinemia : Intermittent vs continuous intravenous methylene blue therapy. ( Mishra, OP; Pandey, M; Prasad, R; Singh, R, 2008) |
"To present a comprehensive review of dapsone-induced methemoglobinemia and its management." | 8.87 | Dapsone-induced methemoglobinemia: a primer for clinicians. ( Barclay, JA; Ibrahim, RB; Ziemba, SE, 2011) |
"To report a case of methemoglobinemia in a patient receiving dapsone for prophylaxis of Pneumocystis carinii pneumonia (PCP)." | 8.80 | Dapsone-induced methemoglobinemia. ( McCarthy, MW; Ward, KE, 1998) |
"The appearance of bite cells associated with methemoglobinemia can be caused by oxidizing drugs such as dapsone in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency or high drug serum levels." | 8.12 | Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria. ( Awan, M; Brown, LE; Gandelman, JS; Geere, M; Hu, Y; Kogan, SC; Leavitt, AD; Pearson, HJ, 2022) |
"Methemoglobinemia is a common complication of dapsone poisoning." | 8.12 | Acute dapsone poisoning with methemoglobinemia: a case report. ( Alilou, M; Benhalima, A; Chajai, I; El Arfaoui, M; El Hamzaoui, H; El Ouazzani, MC, 2022) |
" CASE REPORT A 22-year-old woman, who was diagnosed with multibacillary leprosy, developed dapsone-induced methemoglobinemia and hemolytic anemia, complicated by melioidosis." | 8.02 | Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction. ( Chew, LP; Chua, HH; Fam, TL; Lee, JTH; Muniandy, P; Tang, ASO; Ting, IPL; Wong, QY; Yeo, ST, 2021) |
" We report a case of an 83-year-old female with stage III chronic kidney disease, who was started on high-dose prednisone for nephrotic syndrome and dapsone for pneumocystis jirovecii pneumonia prophylaxis." | 8.02 | Unusual cause of persistent dyspnea in a patient with nephrotic syndrome: dapsone-induced methemoglobinemia. ( Ali, R; Kadhem, S; Mannemuddhu, SS; Ruchi, R, 2021) |
"Dapsone gel is a topical treatment for facial acne in adolescents and adults, and while systemic dapsone therapy is known to be associated with methemoglobinemia, once-daily topical dapsone has been well tolerated with few side effects in large randomized controlled trials." | 7.96 | Severe methemoglobinemia due to topical dapsone misuse in a teenage girl. ( McCarthy, J; McCarthy, P; McFadden, V; Stefanko, N; Yale, S, 2020) |
"Dapsone intoxication can be a life-threatening condition due its enterohepatic recirculation pharmacokinetics, and therefore, persistent methemoglobinemia development." | 7.96 | Whole bowel irrigation in dapsone intoxication with persistent methemoglobinemia. ( Barrios, C; Carboni Bisso, I; Cordero, MP; Gemelli, N; Pina, D, 2020) |
" Numerous testing modalities are performed in the ED focused on an infectious versus pulmonary etiology prior to coming to the conclusion that the source is methemoglobinemia induced by dapsone therapy." | 7.91 | Neutropenia, Hypoxia, and the Complexities of Emergency Medicine: A Case of Dapsone-Induced Methemoglobinemia. ( Blomkalns, A; Iams, A; Vu, S, 2019) |
"This case shows that dapsone-induced mania severity is correlated with methemoglobinemia level, leading for the first time to the hypothesis of a physiopathological mechanism by which dapsone could induce mania." | 7.91 | Methemoglobinemia as a biomarker of dapsone-induced mania severity. ( Ait Tayeb, AEK; Becquemont, L; Colle, R; Corruble, E; David, DJ; de Menthon, M; Lambotte, O; Mesdom, P; Verstuyft, C, 2019) |
" de Martínez Hospital, with cyanosis in face and limb, in poor condition, that consumed dapsone accidentally." | 7.88 | [Methemoglobinemia due to Dapsone: a pediatric case report]. ( Capurso, C; Larroca, MC; Matsuda, M; Paccor, A; Rizzo, E, 2018) |
"We attempted to clarify this issue by comparing the clinical course of methemoglobinemia caused by dapsone and that caused by other toxic agents." | 7.83 | Difference of the clinical course and outcome between dapsone-induced methemoglobinemia and other toxic-agent-induced methemoglobinemia. ( Ahn, S; Kim, WY; Kim, YJ; Lee, JH; Lee, YS; Lim, KS; Oh, BJ; Ryoo, SM; Seo, DW; Sohn, CH, 2016) |
"While methemoglobinemia is a possible complication of chronic dapsone therapy or of acute overdose, serious adverse manifestations related to methemoglobin formation remain rare." | 7.81 | Acute visual loss following dapsone-induced methemoglobinemia and hemolysis. ( Hantson, P; Hanuschk, D; Kozyreff, A; Saint-Marcoux, F; Tafzi, N; Tennstedt, D, 2015) |
"Diaphenylsulfone (DDS: Dapsone) is used for Pneumocystis pneumonia (PCP) prophylaxis, and methemoglobinemia has rarely been reported as a side effect of DDS." | 7.81 | Identifying the Cause of the "Saturation Gap": Two Cases of Dapsone-induced Methemoglobinemia. ( Arita, M; Furuta, K; Hashimoto, T; Ikeda, S; Ikeo, S; Ishida, T; Ito, A; Nishiyama, A; Tachibana, H; Takaiwa, T; Tanaka, M; Tokioka, F; Yokoyama, T; Yoshioka, H, 2015) |
"Among 167 pediatric patients treated for hematologic malignancies or aplastic anemia who received dapsone for PCP prophylaxis, demographic and dapsone treatment data were retrospectively collected." | 7.77 | Dapsone-induced methemoglobinemia: a dose-related occurrence? ( Esbenshade, AJ; Friedman, DL; Ho, RH; Shintani, A; Smith, LA; Zhao, Z, 2011) |
"The curcumin's effect given orally by gavage in single- or multiple-dose regimens on methemoglobinemia induced by dapsone (DDS) was investigated in male Wistar rats." | 7.77 | Curcumin could prevent methemoglobinemia induced by dapsone in rats. ( Alcantara, GK; Bergamaschi, MM; Queiroz, RH; Valério, DA, 2011) |
"Dapsone induces methemoglobinemia by oxidant stress; ethyl pyruvate (EP) is an antioxidant and radical oxygen species scavenger." | 7.74 | The effect of ethyl pyruvate on dapsone-induced methemoglobinemia in rats. ( Jo, YH; Kang, YJ; Kim, K; Kwon, WY; Lee, JH; Shin, SD; Suh, GJ, 2008) |
"This report describes a case of methemoglobinemia in association with dapsone therapy." | 7.73 | Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura. ( Roberts, WD; Schiff, DE; Sue, YJ, 2006) |
"We studied 15 children with acute lymphoblastic leukemia (ALL) receiving dapsone for PCP prophylaxis to determine the frequency of methemoglobinemia, and correlate its occurrence with cytochrome b5 reductase (Cb5R) enzyme levels." | 7.73 | Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for pneumocystis carinii pneumonia (PCP) prophylaxis: a correlation with cytochrome b5 reductase (Cb5R) enzyme levels. ( Athale, UH; Barr, RD; Hoyer, JD; MacDonald, P; Williams, S, 2005) |
"The treatment of two common adverse effects of dapsone (methemoglobinemia and hemolytic anemia) is discussed, and a case of acute dapsone intoxication is described." | 7.68 | Dapsone-induced methemoglobinemia and hemolytic anemia. ( Erstad, BL, 1992) |
" We have attempted to reduce dapsone-dependent methaemoglobinaemia formation in six dermatitis herpetiformis patients stabilised on dapsone by the co-administration of cimetidine." | 7.68 | The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. ( Breckenridge, AM; Coleman, MD; Friedmann, PS; Park, BK; Rhodes, LE; Scott, AK; Verbov, JL, 1992) |
"The authors report 8 cases of Horton's disease and/or polymyalgia rheumatica treated with prednisone with an initially favourable result." | 7.67 | [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica]. ( Celton, H; Doury, P; Eulry, F; Fabresse, FX; Larroque, P; Pattin, S, 1984) |
"Methemoglobinemia and hemolysis are well-known side effects after using high doses of dapsone (4,4'-diaminodiphenylsulfone)." | 7.66 | Dapsone-induced methemoglobinemia and hemolysis in the presence of familial hemoglobinopathy Hasharon and familial methemoglobin reductase deficiency. ( Fryd, CH; Ganer, A; Knobel, B; Rachmilewitz, EA, 1981) |
"Twenty patients with dermatitis herpetiformis treated with di(4-aminophenyl)-sulphone (Dapsone) were analyzed with respect to serum hemopexin concentration as well as some other haematological parameters." | 7.65 | Serum hemopexin in patients with dermatitis herpetiformis on dapsone (di(4-aminophenyl)sulphone). ( Kastrup, W; Lindstedt, G; Lundberg, PA; Mobacken, H, 1975) |
"Dapsone has been utilized for the prevention of Pneumocystis jirovecii pneumonia in immunosuppressed patients including pediatric kidney transplant recipients, in whom trimethoprim-sulfamethoxazole (TMP-SMX) is contraindicated." | 5.62 | Dapsone-induced methemoglobinemia in pediatrics post-renal transplant. ( Hindka, A; Huynh, D; Verghese, PS, 2021) |
" Though these drugs are generally well tolerated, they can result in potentially severe adverse effects." | 5.56 | Murphy's law in force: sequential adverse events encountered during the treatment of Pneumocystis pneumonia (cotrimoxazole-induced acute peripheral neuropathy and primaquine-induced methemoglobinemia). ( Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Saxena, P; Sehgal, IS, 2020) |
"Dapsone (75 mg/day) was begun as adjunctive treatment, and new blister formation ceased." | 5.56 | A Case of Dapsone-induced Mild Methemoglobinemia with Dyspnea and Cyanosis. ( Hayama, Y; Imanishi, H; Sugawara, K; Tsuruta, D; Yoshimoto, N, 2020) |
"Dapsone was suspended and one week later, her methemoglobinemia was absent." | 5.56 | [Methemoglobinemia caused by dapsone. Report of one case]. ( Barnafi, E; Jara, A; Rojas, V; Sepúlveda, RA, 2020) |
"Methylene blue is the first-choice treatment of methemoglobinemia, but it is not readily available in most Korean emergency departments because of an import suspension." | 5.40 | High-dose vitamin C management in dapsone-induced methemoglobinemia. ( Kang, TS; Lee, KW; Park, SY, 2014) |
"Acquired methemoglobinemia is a common, potentially fatal syndrome that can occur as a result of exposure to numerous xenobiotics." | 5.37 | Case files of the medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ: methemoglobinemia following dapsone exposure. ( Canning, J; Levine, M, 2011) |
"Dapsone is a leprostatic agent commonly prescribed for the treatment of patients with leprosy, malaria, and a variety of blistering skin diseases, including dermatitis herpetiformis." | 5.36 | Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia. ( Ashurst, JV; Fritz, WT; Hauger, W; Wasson, MN, 2010) |
"Methylene blue was administered (2 mg/kg intravenously) and the patient rapidly improved." | 5.30 | A case of methemoglobinemia after ingestion of an aphrodisiac, later proven as dapsone. ( Kim, M; Kim, MJ; Lee, JY; Lee, KJ; Lee, SW, 1999) |
"It is the drug of choice for the treatment of leprosy and prophylaxis of malaria." | 5.30 | Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT. ( Barbosa, JC; de Carvalho, D; de Souza, AM; Gouveia, E; Melchior Júnior, E; Queiroz, RH, 1997) |
"Intraoperative cyanosis is most commonly caused by hypoxaemia." | 5.27 | Intraoperative cyanosis: a case of dapsone-induced methaemoglobinaemia. ( Leighton, K; Mayo, W; Robertson, B; Ruedy, J, 1987) |
"A case of methemoglobinemia is reported in one such patient treated with dapsone." | 5.27 | Methemoglobinemia from dapsone therapy for a suspected brown spider bite. ( Iserson, KV, 1985) |
"To present a comprehensive review of dapsone-induced methemoglobinemia and its management." | 4.87 | Dapsone-induced methemoglobinemia: a primer for clinicians. ( Barclay, JA; Ibrahim, RB; Ziemba, SE, 2011) |
"To report a case of methemoglobinemia in a patient receiving dapsone for prophylaxis of Pneumocystis carinii pneumonia (PCP)." | 4.80 | Dapsone-induced methemoglobinemia. ( McCarthy, MW; Ward, KE, 1998) |
"Methemoglobinemia is a common complication of dapsone poisoning." | 4.12 | Acute dapsone poisoning with methemoglobinemia: a case report. ( Alilou, M; Benhalima, A; Chajai, I; El Arfaoui, M; El Hamzaoui, H; El Ouazzani, MC, 2022) |
"The appearance of bite cells associated with methemoglobinemia can be caused by oxidizing drugs such as dapsone in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency or high drug serum levels." | 4.12 | Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria. ( Awan, M; Brown, LE; Gandelman, JS; Geere, M; Hu, Y; Kogan, SC; Leavitt, AD; Pearson, HJ, 2022) |
" CASE REPORT A 22-year-old woman, who was diagnosed with multibacillary leprosy, developed dapsone-induced methemoglobinemia and hemolytic anemia, complicated by melioidosis." | 4.02 | Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction. ( Chew, LP; Chua, HH; Fam, TL; Lee, JTH; Muniandy, P; Tang, ASO; Ting, IPL; Wong, QY; Yeo, ST, 2021) |
" We report a case of an 83-year-old female with stage III chronic kidney disease, who was started on high-dose prednisone for nephrotic syndrome and dapsone for pneumocystis jirovecii pneumonia prophylaxis." | 4.02 | Unusual cause of persistent dyspnea in a patient with nephrotic syndrome: dapsone-induced methemoglobinemia. ( Ali, R; Kadhem, S; Mannemuddhu, SS; Ruchi, R, 2021) |
"Dapsone gel is a topical treatment for facial acne in adolescents and adults, and while systemic dapsone therapy is known to be associated with methemoglobinemia, once-daily topical dapsone has been well tolerated with few side effects in large randomized controlled trials." | 3.96 | Severe methemoglobinemia due to topical dapsone misuse in a teenage girl. ( McCarthy, J; McCarthy, P; McFadden, V; Stefanko, N; Yale, S, 2020) |
"Dapsone intoxication can be a life-threatening condition due its enterohepatic recirculation pharmacokinetics, and therefore, persistent methemoglobinemia development." | 3.96 | Whole bowel irrigation in dapsone intoxication with persistent methemoglobinemia. ( Barrios, C; Carboni Bisso, I; Cordero, MP; Gemelli, N; Pina, D, 2020) |
"This case shows that dapsone-induced mania severity is correlated with methemoglobinemia level, leading for the first time to the hypothesis of a physiopathological mechanism by which dapsone could induce mania." | 3.91 | Methemoglobinemia as a biomarker of dapsone-induced mania severity. ( Ait Tayeb, AEK; Becquemont, L; Colle, R; Corruble, E; David, DJ; de Menthon, M; Lambotte, O; Mesdom, P; Verstuyft, C, 2019) |
" Numerous testing modalities are performed in the ED focused on an infectious versus pulmonary etiology prior to coming to the conclusion that the source is methemoglobinemia induced by dapsone therapy." | 3.91 | Neutropenia, Hypoxia, and the Complexities of Emergency Medicine: A Case of Dapsone-Induced Methemoglobinemia. ( Blomkalns, A; Iams, A; Vu, S, 2019) |
" de Martínez Hospital, with cyanosis in face and limb, in poor condition, that consumed dapsone accidentally." | 3.88 | [Methemoglobinemia due to Dapsone: a pediatric case report]. ( Capurso, C; Larroca, MC; Matsuda, M; Paccor, A; Rizzo, E, 2018) |
"We attempted to clarify this issue by comparing the clinical course of methemoglobinemia caused by dapsone and that caused by other toxic agents." | 3.83 | Difference of the clinical course and outcome between dapsone-induced methemoglobinemia and other toxic-agent-induced methemoglobinemia. ( Ahn, S; Kim, WY; Kim, YJ; Lee, JH; Lee, YS; Lim, KS; Oh, BJ; Ryoo, SM; Seo, DW; Sohn, CH, 2016) |
"Dapsone is an extensively Used drug for the treatment of leprosy as well as'some other clinical problems worldwide: Its use has been predicted to increase further, especially in non leprosy conditions." | 3.83 | Dapsone: An Update. ( Aruna, B; Kallappa, H; Karjigi, S; Kusuma, MR; Murthy, SC; Reddy, YN, 2016) |
"While methemoglobinemia is a possible complication of chronic dapsone therapy or of acute overdose, serious adverse manifestations related to methemoglobin formation remain rare." | 3.81 | Acute visual loss following dapsone-induced methemoglobinemia and hemolysis. ( Hantson, P; Hanuschk, D; Kozyreff, A; Saint-Marcoux, F; Tafzi, N; Tennstedt, D, 2015) |
"Diaphenylsulfone (DDS: Dapsone) is used for Pneumocystis pneumonia (PCP) prophylaxis, and methemoglobinemia has rarely been reported as a side effect of DDS." | 3.81 | Identifying the Cause of the "Saturation Gap": Two Cases of Dapsone-induced Methemoglobinemia. ( Arita, M; Furuta, K; Hashimoto, T; Ikeda, S; Ikeo, S; Ishida, T; Ito, A; Nishiyama, A; Tachibana, H; Takaiwa, T; Tanaka, M; Tokioka, F; Yokoyama, T; Yoshioka, H, 2015) |
"Among 167 pediatric patients treated for hematologic malignancies or aplastic anemia who received dapsone for PCP prophylaxis, demographic and dapsone treatment data were retrospectively collected." | 3.77 | Dapsone-induced methemoglobinemia: a dose-related occurrence? ( Esbenshade, AJ; Friedman, DL; Ho, RH; Shintani, A; Smith, LA; Zhao, Z, 2011) |
" The resulting methaemoglobinaemia and lactic acidosis persisted despite treatment with methylene blue, multiple-dose activated charcoal and ascorbic acid." | 3.77 | Acute dapsone overdose: the effects of continuous veno-venous haemofiltration on the elimination of dapsone. ( Anstey, CM; Edstein, MD; Gorton, CJ; Masurkar, VA, 2011) |
"Dapsone is used as an antibiotic for leprosy and for dermatological disorders and may cause methemoglobinemia." | 3.76 | Dapsone intoxication: clinical course and characteristics. ( Cha, KC; Do, HH; Hwang, SO; Ji, HJ; Kim, H; Lee, CC; Lee, KH; Park, KH; Park, SM; Singer, AJ, 2010) |
"We studied 15 children with acute lymphoblastic leukemia (ALL) receiving dapsone for PCP prophylaxis to determine the frequency of methemoglobinemia, and correlate its occurrence with cytochrome b5 reductase (Cb5R) enzyme levels." | 3.73 | Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for pneumocystis carinii pneumonia (PCP) prophylaxis: a correlation with cytochrome b5 reductase (Cb5R) enzyme levels. ( Athale, UH; Barr, RD; Hoyer, JD; MacDonald, P; Williams, S, 2005) |
"Dapsone, used for prevention of Pneumocystis jirovecii infections, has been reported to cause hemolytic anemia and methemoglobinemia; its tolerability in solid organ transplant recipients is not well described." | 3.73 | Complications related to dapsone use for Pneumocystis jirovecii pneumonia prophylaxis in solid organ transplant recipients. ( Barton, TD; Bloom, RD; Blumberg, EA; Chojnowski, D; Doyle, AM; Goral, S; Korenda, K; Lee, I, 2005) |
"This report describes a case of methemoglobinemia in association with dapsone therapy." | 3.73 | Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura. ( Roberts, WD; Schiff, DE; Sue, YJ, 2006) |
"We report the case of a 26 year-old female who was treated on numerous occasions for methemoglobinemia believed secondary to surreptitious abuse of dapsone as part of a factitious disorder." | 3.70 | Factitious methemoglobinemia. ( Carr, KM; Caruana, LC; Elias, L; Rabinowitz, I, 1999) |
" Spectrophotometric methods were used to analyze methemoglobinemia (MHbp) and dapsonemia (DDSp)." | 3.70 | Clinical and laboratory parameters in dapsone acute intoxication. ( Carrazza, FR; Carrazza, MZ; Oga, S, 2000) |
"There are many case reports of dapsone overdose in adults but only a few reports of dapsone-induced methemoglobinemia in children." | 3.69 | Acute dapsone intoxication: a pediatric case report. ( MacDonald, RD; McGuigan, MA, 1997) |
"Acute poisoning from excessive dapsone (4,4-diaminodiphenylsulfone) intake in uncommon in the United States; no cases were reported during 1992." | 3.69 | Severe accidental dapsone overdose. ( Bailie, GR; McGoldrick, MD, 1995) |
"The treatment of two common adverse effects of dapsone (methemoglobinemia and hemolytic anemia) is discussed, and a case of acute dapsone intoxication is described." | 3.68 | Dapsone-induced methemoglobinemia and hemolytic anemia. ( Erstad, BL, 1992) |
" We have attempted to reduce dapsone-dependent methaemoglobinaemia formation in six dermatitis herpetiformis patients stabilised on dapsone by the co-administration of cimetidine." | 3.68 | The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. ( Breckenridge, AM; Coleman, MD; Friedmann, PS; Park, BK; Rhodes, LE; Scott, AK; Verbov, JL, 1992) |
"The authors report 8 cases of Horton's disease and/or polymyalgia rheumatica treated with prednisone with an initially favourable result." | 3.67 | [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica]. ( Celton, H; Doury, P; Eulry, F; Fabresse, FX; Larroque, P; Pattin, S, 1984) |
"Methemoglobinemia and hemolysis are well-known side effects after using high doses of dapsone (4,4'-diaminodiphenylsulfone)." | 3.66 | Dapsone-induced methemoglobinemia and hemolysis in the presence of familial hemoglobinopathy Hasharon and familial methemoglobin reductase deficiency. ( Fryd, CH; Ganer, A; Knobel, B; Rachmilewitz, EA, 1981) |
"5 g of 4,4'-diamino, diphenyl sulphone (dapsone) taken as a suicide attempt in a patient on long-term therapy for tuberculoid leprosy resulted in permanent bilateral retinal necrosis, previously unreported side effect of this drug." | 3.66 | Permanent retinal damage following massive dapsone overdose. ( Agnello, R; Chester, GH; Holt, K; Kenner, DJ, 1980) |
"Twenty patients with dermatitis herpetiformis treated with di(4-aminophenyl)-sulphone (Dapsone) were analyzed with respect to serum hemopexin concentration as well as some other haematological parameters." | 3.65 | Serum hemopexin in patients with dermatitis herpetiformis on dapsone (di(4-aminophenyl)sulphone). ( Kastrup, W; Lindstedt, G; Lundberg, PA; Mobacken, H, 1975) |
"Dapsone is an antibacterial sulfonamide with anti-inflammatory property, which showed therapeutic activity in patients with immune thrombocytopenia (ITP); the activity in patients who showed refractoriness to rituximab is unknown." | 2.77 | Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab. ( Chiozzotto, M; Fanin, R; Marin, L; Puglisi, S; Volpetti, S; Zaja, F, 2012) |
"1." | 2.39 | Dapsone toxicity: some current perspectives. ( Coleman, MD, 1995) |
"Dapsone has been utilized for the prevention of Pneumocystis jirovecii pneumonia in immunosuppressed patients including pediatric kidney transplant recipients, in whom trimethoprim-sulfamethoxazole (TMP-SMX) is contraindicated." | 1.62 | Dapsone-induced methemoglobinemia in pediatrics post-renal transplant. ( Hindka, A; Huynh, D; Verghese, PS, 2021) |
" Though these drugs are generally well tolerated, they can result in potentially severe adverse effects." | 1.56 | Murphy's law in force: sequential adverse events encountered during the treatment of Pneumocystis pneumonia (cotrimoxazole-induced acute peripheral neuropathy and primaquine-induced methemoglobinemia). ( Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Saxena, P; Sehgal, IS, 2020) |
"Dapsone (75 mg/day) was begun as adjunctive treatment, and new blister formation ceased." | 1.56 | A Case of Dapsone-induced Mild Methemoglobinemia with Dyspnea and Cyanosis. ( Hayama, Y; Imanishi, H; Sugawara, K; Tsuruta, D; Yoshimoto, N, 2020) |
"Dapsone was suspended and one week later, her methemoglobinemia was absent." | 1.56 | [Methemoglobinemia caused by dapsone. Report of one case]. ( Barnafi, E; Jara, A; Rojas, V; Sepúlveda, RA, 2020) |
"Dapsone clearance was enhanced by ECTR, especially by IHD-HP." | 1.43 | Extracorporeal treatments in a dapsone overdose: a case report. ( Bernier-Jean, A; Bouchard, J; Brindamour, D; Cormier, M; Déziel, C; Ghannoum, M, 2016) |
"Methylene blue is the first-choice treatment of methemoglobinemia, but it is not readily available in most Korean emergency departments because of an import suspension." | 1.40 | High-dose vitamin C management in dapsone-induced methemoglobinemia. ( Kang, TS; Lee, KW; Park, SY, 2014) |
"Methylene blue was administered and the methaemoglobin level dropped to 5% within three days." | 1.39 | [Dapsone-induced methaemoglobinaemia]. ( Mrgan, M; Rytter, D, 2013) |
"Methemoglobinemia is a rare pathology that results from the oxidation of iron in the hemoglobin molecule." | 1.38 | Two cases of acquired methemoglobinemia. ( Bergmans, D; Hall, A; Schnabel, R; Stessel, B, 2012) |
"Acquired methemoglobinemia is a common, potentially fatal syndrome that can occur as a result of exposure to numerous xenobiotics." | 1.37 | Case files of the medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ: methemoglobinemia following dapsone exposure. ( Canning, J; Levine, M, 2011) |
"Dapsone is a leprostatic agent commonly prescribed for the treatment of patients with leprosy, malaria, and a variety of blistering skin diseases, including dermatitis herpetiformis." | 1.36 | Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia. ( Ashurst, JV; Fritz, WT; Hauger, W; Wasson, MN, 2010) |
"Dapsone is a leprostatic agent commonly prescribed for the management of leprosy, malaria, and the immunosuppression-induced infections of Pneumocystis carinii and Toxoplasma gondii." | 1.34 | The recognition, physiology, and treatment of medication-induced methemoglobinemia: a case report. ( Glickman, RS; Karlis, V; Turner, MD, 2007) |
"Dapsone was the most common etiology of acquired methemoglobinemia, accounting for 42% of all cases." | 1.32 | Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. ( Ash-Bernal, R; Wise, R; Wright, SM, 2004) |
"It is the drug of choice for the treatment of leprosy and prophylaxis of malaria." | 1.30 | Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT. ( Barbosa, JC; de Carvalho, D; de Souza, AM; Gouveia, E; Melchior Júnior, E; Queiroz, RH, 1997) |
"Methylene blue was administered (2 mg/kg intravenously) and the patient rapidly improved." | 1.30 | A case of methemoglobinemia after ingestion of an aphrodisiac, later proven as dapsone. ( Kim, M; Kim, MJ; Lee, JY; Lee, KJ; Lee, SW, 1999) |
" Daily dosing of mice with dapsone (50 mg kg-1, p." | 1.29 | A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite. ( Ahmadi, M; Khalaf, LF; Nicholls, PJ; Smith, HJ, 1996) |
"Methemoglobinemia is caused by many factors, both congenital and acquired." | 1.29 | Chronic methemoglobinemia: improving hemoglobin saturation monitoring during anesthesia. ( Bourke, DL; Mackenzie, CF; Sprung, J; Thomas, P, 1994) |
" The 3,3'DDS and MADDT derivatives were both significantly less toxic compared with DDS." | 1.28 | An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro. ( Coleman, MD; Hussain, F; Park, BK; Storr, RC; Tingle, MD, 1991) |
"Intraoperative cyanosis is most commonly caused by hypoxaemia." | 1.27 | Intraoperative cyanosis: a case of dapsone-induced methaemoglobinaemia. ( Leighton, K; Mayo, W; Robertson, B; Ruedy, J, 1987) |
"A case of methemoglobinemia is reported in one such patient treated with dapsone." | 1.27 | Methemoglobinemia from dapsone therapy for a suspected brown spider bite. ( Iserson, KV, 1985) |
"It was concluded that haemolytic anaemia after dapsone therapy is not due to a functional impairment of the enzyme." | 1.26 | Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage. ( Allegra, F; De Panfilis, G; Manfredi, G; Zampetti, M, 1979) |
"A description of the clinical and biochemical course is given for a patient who developed haemolysis and methaemoglobinaemia following dapsone therapy in high dosage for 2 weeks." | 1.26 | High dose dapsone toxicity. ( Goldwein, MI; Shelley, WB, 1976) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 42 (22.46) | 18.7374 |
1990's | 40 (21.39) | 18.2507 |
2000's | 35 (18.72) | 29.6817 |
2010's | 42 (22.46) | 24.3611 |
2020's | 28 (14.97) | 2.80 |
Authors | Studies |
---|---|
Cook, A | 1 |
Grant, S | 1 |
Kapeluk, S | 1 |
Steele, P | 1 |
Sriperumbuduri, S | 1 |
Hesketh, C | 1 |
Clark, EG | 1 |
Sapra, D | 1 |
Singh, GK | 1 |
Bahuguna, A | 1 |
Das, P | 1 |
Gupta, A | 1 |
Jacob, G | 1 |
Schorr, M | 1 |
Moist, LM | 1 |
Yoshida, M | 1 |
Nambu, R | 1 |
Yasuda, R | 1 |
Sakaguchi, H | 1 |
Hara, T | 1 |
Iwama, I | 1 |
Mizuochi, T | 1 |
Yoshida, T | 1 |
Nishimura, K | 1 |
Murabe, H | 1 |
Yokota, T | 1 |
Zia, S | 1 |
Kazim, SN | 1 |
Yousif, AOM | 1 |
Kuthbudeen, MW | 1 |
Hu, Y | 3 |
Geere, M | 3 |
Awan, M | 3 |
Leavitt, AD | 3 |
Brown, LE | 3 |
Pearson, HJ | 3 |
Gandelman, JS | 3 |
Kogan, SC | 3 |
El Hamzaoui, H | 3 |
Chajai, I | 3 |
El Ouazzani, MC | 3 |
Benhalima, A | 3 |
El Arfaoui, M | 3 |
Alilou, M | 3 |
Vandermeersch, D | 1 |
Sansen, PY | 1 |
Pothen, L | 1 |
Condren, J | 1 |
Fitzgerald, D | 1 |
Ezhilarasan, D | 1 |
Yale, S | 1 |
Stefanko, N | 1 |
McCarthy, P | 1 |
McFadden, V | 1 |
McCarthy, J | 1 |
Sahu, KK | 2 |
Lal, A | 2 |
Mishra, AK | 2 |
George, SV | 2 |
Saxena, P | 1 |
Muthu, V | 1 |
Dhooria, S | 1 |
Sehgal, IS | 1 |
Prasad, KT | 1 |
Agarwal, R | 1 |
Siddiqui, AD | 1 |
Bailey, NJ | 1 |
Kraft, RM | 1 |
Schouten, WM | 1 |
Carboni Bisso, I | 1 |
Gemelli, N | 1 |
Cordero, MP | 1 |
Barrios, C | 1 |
Pina, D | 1 |
Lewis, JS | 1 |
Jacobs, ZG | 1 |
Tan, YA | 1 |
Ng, KC | 1 |
Cheo, SW | 1 |
Khoo, TT | 1 |
Low, QJ | 1 |
Jonkers, BRP | 1 |
Cobanoglu, G | 1 |
Blok, EJ | 1 |
Köbben, JJ | 1 |
van der Helm, MW | 1 |
van Hoof, IJAM | 1 |
Tintu, AN | 1 |
Bethlehem, C | 2 |
Versmissen, J | 1 |
Hindka, A | 1 |
Huynh, D | 1 |
Verghese, PS | 1 |
Mannemuddhu, SS | 1 |
Ali, R | 1 |
Kadhem, S | 1 |
Ruchi, R | 1 |
Gallardo, CA | 1 |
Fan, BE | 1 |
Lim, KGE | 1 |
Kuperan, P | 1 |
Hayama, Y | 1 |
Imanishi, H | 1 |
Yoshimoto, N | 1 |
Sugawara, K | 1 |
Tsuruta, D | 1 |
Sepúlveda, RA | 1 |
Barnafi, E | 1 |
Rojas, V | 1 |
Jara, A | 1 |
Tripathi, T | 1 |
Singh, AR | 1 |
Kapoor, R | 1 |
Sinha, A | 1 |
Ghosh, S | 1 |
Kaur, K | 1 |
Pokhariya, D | 1 |
Maity, S | 1 |
Tapadar, A | 1 |
Chandra, A | 1 |
Tang, ASO | 1 |
Wong, QY | 1 |
Yeo, ST | 1 |
Ting, IPL | 1 |
Lee, JTH | 1 |
Fam, TL | 1 |
Chew, LP | 1 |
Chua, HH | 1 |
Muniandy, P | 1 |
Mack, J | 1 |
Mian, A | 1 |
Salim, SA | 1 |
Ramachandran Nair, L | 1 |
Palabindala, V | 1 |
Craici, I | 1 |
Karjigi, S | 1 |
Murthy, SC | 1 |
Kallappa, H | 1 |
Kusuma, MR | 1 |
Aruna, B | 1 |
Reddy, YN | 1 |
Mahapatra, MK | 1 |
Giri, PP | 1 |
Paccor, A | 1 |
Matsuda, M | 1 |
Capurso, C | 1 |
Rizzo, E | 1 |
Larroca, MC | 1 |
Colle, R | 1 |
Ait Tayeb, AEK | 1 |
Mesdom, P | 1 |
de Menthon, M | 1 |
Becquemont, L | 1 |
Verstuyft, C | 1 |
David, DJ | 1 |
Lambotte, O | 1 |
Corruble, E | 1 |
Vu, S | 1 |
Iams, A | 1 |
Blomkalns, A | 1 |
Torabi, J | 1 |
Campbell, A | 1 |
Nair, G | 1 |
Patel, GL | 1 |
Miura, Y | 1 |
Graham, JA | 1 |
Chang, YJ | 1 |
Ali, H | 1 |
Draper, A | 1 |
Chua, F | 1 |
Burke, P | 1 |
Jahangir, K | 1 |
Kolber, MR | 1 |
Mitsides, N | 1 |
Green, D | 1 |
Middleton, R | 1 |
New, D | 1 |
Lamerton, E | 1 |
Allen, J | 1 |
Redshaw, J | 1 |
Chadwick, PR | 1 |
Subudhi, CP | 1 |
Wood, G | 1 |
Wieringa, A | 1 |
Hoogendoorn, M | 1 |
van der Maten, J | 1 |
van Roon, EN | 1 |
Park, SY | 1 |
Lee, KW | 1 |
Kang, TS | 1 |
Rytter, D | 1 |
Mrgan, M | 1 |
Senthilkumaran, S | 1 |
Benita, F | 1 |
Ananth, C | 1 |
Thirumalaikolundusubramanian, P | 2 |
Malasingam, R | 1 |
Ranganathan, D | 1 |
Jeyaseelan, L | 1 |
Ramanathan, K | 1 |
Jacks, M | 1 |
Owens, J | 1 |
John, GT | 1 |
Watton, C | 1 |
Smith, K | 1 |
Carter, E | 1 |
Swartzentruber, GS | 1 |
Yanta, JH | 1 |
Pizon, AF | 1 |
Hanuschk, D | 1 |
Kozyreff, A | 1 |
Tafzi, N | 1 |
Tennstedt, D | 1 |
Hantson, P | 1 |
Saint-Marcoux, F | 1 |
Furuta, K | 1 |
Ikeo, S | 1 |
Takaiwa, T | 1 |
Ikeda, S | 1 |
Nishiyama, A | 1 |
Yokoyama, T | 1 |
Ito, A | 1 |
Tokioka, F | 1 |
Tanaka, M | 1 |
Yoshioka, H | 1 |
Tachibana, H | 1 |
Arita, M | 1 |
Hashimoto, T | 1 |
Ishida, T | 1 |
Albuquerque, RV | 1 |
Malcher, NS | 1 |
Amado, LL | 1 |
Coleman, MD | 10 |
Dos Santos, DC | 1 |
Borges, RS | 1 |
Valente, SA | 1 |
Valente, VC | 1 |
Monteiro, MC | 1 |
Graff, DM | 1 |
Bosse, GM | 1 |
Sullivan, J | 1 |
Kim, YJ | 1 |
Sohn, CH | 1 |
Ryoo, SM | 1 |
Ahn, S | 1 |
Seo, DW | 1 |
Lee, YS | 1 |
Lee, JH | 2 |
Oh, BJ | 1 |
Lim, KS | 1 |
Kim, WY | 1 |
Ghannoum, M | 1 |
Cormier, M | 1 |
Bernier-Jean, A | 1 |
Brindamour, D | 1 |
Déziel, C | 1 |
Bouchard, J | 1 |
O'Dwyer, D | 1 |
McElvaney, NG | 1 |
Jo, YH | 1 |
Kwon, WY | 1 |
Kim, K | 1 |
Shin, SD | 1 |
Kang, YJ | 1 |
Suh, GJ | 1 |
Commondoor, R | 1 |
Murray, MJ | 1 |
Walker, JG | 1 |
Kadia, T | 1 |
Brown, L | 1 |
Juneja, HS | 1 |
de Groot, JF | 1 |
Ashurst, JV | 1 |
Wasson, MN | 1 |
Hauger, W | 1 |
Fritz, WT | 1 |
Moulis, G | 1 |
Bagheri, H | 1 |
Saint Martory, J | 1 |
Bernard, P | 1 |
Montastruc, JL | 1 |
Park, KH | 1 |
Kim, H | 1 |
Lee, CC | 1 |
Cha, KC | 1 |
Park, SM | 1 |
Ji, HJ | 1 |
Do, HH | 1 |
Lee, KH | 1 |
Hwang, SO | 1 |
Singer, AJ | 1 |
Nessim, SJ | 1 |
Lipman, ML | 1 |
Narayanan, N | 1 |
Conlon, N | 1 |
Seigne, P | 1 |
Subramaniam, A | 1 |
Corallo, C | 1 |
Nagappan, R | 1 |
Esbenshade, AJ | 1 |
Ho, RH | 1 |
Shintani, A | 1 |
Zhao, Z | 1 |
Smith, LA | 1 |
Friedman, DL | 1 |
Pallais, JC | 1 |
Mackool, BT | 1 |
Pitman, MB | 1 |
Abouraya, M | 1 |
Sacco, JC | 1 |
Hayes, K | 1 |
Thomas, S | 1 |
Kitchens, CS | 1 |
Trepanier, LA | 1 |
Bergamaschi, MM | 1 |
Alcantara, GK | 1 |
Valério, DA | 1 |
Queiroz, RH | 3 |
Canning, J | 1 |
Levine, M | 1 |
Barclay, JA | 1 |
Ziemba, SE | 1 |
Ibrahim, RB | 1 |
Masurkar, VA | 1 |
Edstein, MD | 1 |
Gorton, CJ | 1 |
Anstey, CM | 1 |
Spoon, KC | 1 |
Ramar, K | 1 |
Zaja, F | 1 |
Marin, L | 1 |
Chiozzotto, M | 1 |
Puglisi, S | 1 |
Volpetti, S | 1 |
Fanin, R | 1 |
Piette, EW | 1 |
Werth, VP | 1 |
Stichtenoth, D | 1 |
Hall, A | 1 |
Stessel, B | 1 |
Bergmans, D | 1 |
Schnabel, R | 1 |
Bryant, SM | 1 |
Pittman, LM | 1 |
Groeper, K | 1 |
Katcher, K | 1 |
Tobias, JD | 1 |
Salamat, A | 1 |
Watson, HG | 1 |
ALEXANDER, JO | 1 |
FISHER, I | 2 |
ORKIN, M | 2 |
Sharif, F | 1 |
Hussey, S | 1 |
Gill, D | 1 |
Asrress, KN | 1 |
Wathen, CG | 1 |
Gorard, DA | 1 |
Ash-Bernal, R | 1 |
Wise, R | 1 |
Wright, SM | 1 |
Williams, S | 1 |
MacDonald, P | 1 |
Hoyer, JD | 1 |
Barr, RD | 1 |
Athale, UH | 1 |
Lee, I | 1 |
Barton, TD | 1 |
Goral, S | 1 |
Doyle, AM | 1 |
Bloom, RD | 1 |
Chojnowski, D | 1 |
Korenda, K | 1 |
Blumberg, EA | 1 |
Talarico, JF | 1 |
Metro, DG | 1 |
Dunford, LM | 1 |
Roy, DM | 1 |
Hahn, TE | 1 |
Padmanabhan, S | 1 |
Segal, BH | 1 |
Almyroudis, N | 1 |
McCarthy, PL | 1 |
Battiwalla, M | 1 |
Shadnia, S | 1 |
Rahimi, M | 1 |
Moeinsadat, M | 1 |
Vesal, G | 1 |
Donyavi, M | 1 |
Abdollahi, M | 1 |
Hohenhaus, M | 1 |
Schiff, DE | 1 |
Roberts, WD | 1 |
Sue, YJ | 1 |
Matisoff, AJ | 1 |
Panni, MK | 1 |
Sener, O | 1 |
Doganci, L | 1 |
Safali, M | 1 |
Besirbellioglu, B | 1 |
Bulucu, F | 1 |
Pahsa, A | 1 |
Choi, A | 1 |
Sarang, A | 1 |
Turner, MD | 1 |
Karlis, V | 1 |
Glickman, RS | 1 |
Mehta, M | 3 |
Prasad, R | 1 |
Singh, R | 1 |
Mishra, OP | 1 |
Pandey, M | 1 |
Endre, ZH | 1 |
Charlesworth, JA | 1 |
Macdonald, GJ | 1 |
Woodbridge, L | 1 |
Revuz, J | 2 |
Hornac, P | 2 |
Magna, LA | 1 |
Beiguelman, B | 1 |
Doury, P | 1 |
Fabresse, FX | 1 |
Pattin, S | 1 |
Eulry, F | 1 |
Celton, H | 1 |
Larroque, P | 1 |
Ganer, A | 1 |
Knobel, B | 1 |
Fryd, CH | 1 |
Rachmilewitz, EA | 1 |
Bernstein, JE | 1 |
Lorincz, AL | 1 |
Lambert, M | 1 |
Sonnet, J | 1 |
Mahieu, P | 1 |
Hassoun, A | 1 |
De Prost, Y | 1 |
Galacteros, F | 1 |
Penev, M | 1 |
Touraine, R | 1 |
Subramanyam, V | 1 |
Subbiah, B | 1 |
Chiranjeevi, V | 1 |
Selvaraj, B | 1 |
Chelliah, T | 1 |
Subramaniam, R | 1 |
Kenner, DJ | 1 |
Holt, K | 1 |
Agnello, R | 1 |
Chester, GH | 1 |
Szeremeta, W | 1 |
Dohar, JE | 1 |
McGoldrick, MD | 1 |
Bailie, GR | 1 |
Rydzewski, B | 1 |
Davis, R | 1 |
Gomber, S | 1 |
Singh, RP | 1 |
Chawla, R | 3 |
Gupta, R | 1 |
Sharma, S | 1 |
Sprung, J | 1 |
Bourke, DL | 1 |
Mackenzie, CF | 1 |
Thomas, P | 1 |
Gurnani, A | 1 |
Bhattacharya, A | 2 |
Sheela, A | 1 |
Thachil, RT | 1 |
Sridhar, CB | 1 |
Mathews, LM | 1 |
Mathews, PJ | 1 |
Wagner, A | 1 |
Marosi, C | 1 |
Binder, M | 1 |
Röggla, G | 1 |
Staudinger, T | 1 |
Keil, F | 1 |
Locker, GJ | 1 |
Frass, M | 1 |
Pirmohamed, M | 1 |
Williams, D | 1 |
Tingle, MD | 4 |
Barry, M | 1 |
Khoo, SH | 1 |
O'Mahony, C | 1 |
Wilkins, EG | 1 |
Breckenridge, AM | 6 |
Park, BK | 9 |
Sin, DD | 1 |
Shafran, SD | 1 |
Driver, JA | 1 |
Lynn, J | 1 |
Dhanjal, US | 1 |
Hoetelmans, RM | 1 |
Otten, JM | 1 |
Koks, CH | 1 |
Soesan, M | 1 |
Beijnen, JH | 1 |
Ahmadi, M | 1 |
Khalaf, LF | 1 |
Smith, HJ | 1 |
Nicholls, PJ | 1 |
Landers, D | 1 |
Bergin, C | 1 |
O'Leary, A | 1 |
Merry, C | 1 |
Keating, S | 1 |
Mulcahy, F | 1 |
MacDonald, RD | 1 |
McGuigan, MA | 1 |
Ferguson, AJ | 1 |
Lavery, GG | 1 |
Rausch-Madison, S | 1 |
Mohsenifar, Z | 1 |
Plotkin, JS | 1 |
Buell, JF | 1 |
Njoku, MJ | 1 |
Wilson, S | 1 |
Kuo, PC | 1 |
Bartlett, ST | 1 |
Howell, C | 1 |
Johnson, LB | 1 |
Melchior Júnior, E | 1 |
de Souza, AM | 1 |
Gouveia, E | 1 |
Barbosa, JC | 1 |
de Carvalho, D | 1 |
Andrzejowski, J | 1 |
Ward, KE | 1 |
McCarthy, MW | 1 |
Kundra, P | 1 |
Kabra, NS | 1 |
Nanavati, RN | 1 |
Srinivasan, G | 1 |
Southgate, HJ | 1 |
Masterson, R | 1 |
Lee, SW | 1 |
Lee, JY | 1 |
Lee, KJ | 1 |
Kim, M | 1 |
Kim, MJ | 1 |
Carr, KM | 1 |
Elias, L | 1 |
Caruana, LC | 1 |
Rabinowitz, I | 1 |
Seaton, RA | 1 |
Nathwani, D | 1 |
Kirk, J | 1 |
France, AJ | 1 |
Craig, D | 1 |
Cadden, IS | 1 |
Gormley, WP | 1 |
Riley, MS | 1 |
Jones, FG | 1 |
McMullin, MF | 1 |
Solheim, L | 1 |
Brun, AC | 1 |
Greibrokk, TS | 1 |
Jacobsen, D | 1 |
Fossum, C | 1 |
Carrazza, MZ | 1 |
Carrazza, FR | 1 |
Oga, S | 1 |
Falkenhahn, M | 1 |
Kannan, S | 1 |
O'Kane, M | 1 |
Ipsen, SE | 1 |
Hansen, VE | 1 |
Freund, YR | 1 |
Dousman, L | 1 |
Riccio, ES | 1 |
Sato, B | 1 |
MacGregor, JT | 1 |
Mohagheghpour, N | 1 |
Kaur, I | 1 |
Agnihotri, N | 1 |
Dogra, S | 1 |
Ganguly, NK | 1 |
Lewis, S | 1 |
Clark, P | 1 |
McCrea, S | 1 |
Veggi, LM | 1 |
Crocenzi, FA | 1 |
Roma, MG | 1 |
Dawson, PA | 1 |
Pellegrino, JM | 1 |
Sánchez Pozzi, EJ | 1 |
Mottino, AD | 1 |
Malfará, WR | 1 |
Pereira, CP | 1 |
Santos, AC | 1 |
Elonen, E | 1 |
Neuvonen, PJ | 1 |
Halmekoski, J | 1 |
Mattila, MJ | 1 |
Manfredi, G | 1 |
De Panfilis, G | 1 |
Zampetti, M | 1 |
Allegra, F | 1 |
Riceputi, G | 1 |
Biagioli, R | 1 |
Guardigni, L | 1 |
Dradi, C | 1 |
Pretolani, E | 1 |
Fabbri, F | 1 |
Lang, PG | 1 |
Wilson, JR | 1 |
Harris, JW | 1 |
Shelley, WB | 1 |
Goldwein, MI | 1 |
Graham, WR | 1 |
Kastrup, W | 1 |
Lindstedt, G | 1 |
Lundberg, PA | 1 |
Mobacken, H | 1 |
Russell, RM | 1 |
Rhodes, LE | 1 |
Scott, AK | 2 |
Verbov, JL | 1 |
Friedmann, PS | 1 |
Trillo, RA | 1 |
Aukburg, S | 1 |
Erstad, BL | 1 |
Hussain, F | 1 |
Storr, RC | 1 |
Gallant, JE | 1 |
Hoehn-Saric, E | 1 |
Smith, MD | 1 |
Hoaksey, PE | 1 |
Winn, MJ | 2 |
Nayak, US | 1 |
Gandhi, DJ | 1 |
Shah, AR | 1 |
Reiter, WM | 1 |
Cimoch, PJ | 1 |
Mayo, W | 1 |
Leighton, K | 1 |
Robertson, B | 1 |
Ruedy, J | 1 |
Rosove, MH | 1 |
Harwig, SS | 1 |
Ahmed, RA | 1 |
Frucht, U | 1 |
Gramm, HJ | 1 |
Dennhardt, R | 1 |
Iserson, KV | 1 |
Goldstein, BD | 1 |
Hjelm, M | 1 |
de Verdier, CH | 1 |
Cucinell, SA | 2 |
Israili, ZH | 1 |
Dayton, PG | 1 |
Khaire, DS | 1 |
Magar, NG | 1 |
Szajewski, JM | 1 |
Dorywalski, T | 1 |
Tomecka, Z | 1 |
Sabiniewicz, M | 1 |
Gordon, GR | 1 |
Shafizadeh, AG | 1 |
Peters, JH | 1 |
Benöhr, HC | 1 |
Huelsekopf, D | 1 |
Kohn, R | 1 |
Bairrington, JD | 1 |
Sulkowski, TS | 1 |
Merritt, JH | 1 |
Bernardini, AT | 1 |
Clyde, DF | 1 |
Rebert, CC | 1 |
McCarthy, VC | 1 |
Dawkins, AT | 1 |
Kramer, PA | 1 |
Glader, BE | 1 |
Li, TK | 1 |
Cooke, TJ | 1 |
Cohen, RJ | 1 |
Sachs, JR | 1 |
Wicker, DJ | 1 |
Conrad, ME | 1 |
Scott, GL | 1 |
Cream, JJ | 1 |
Schvartsman, S | 1 |
Borges, MA | 1 |
Mello, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Intravenous Lidocaine Infusion in the Management of Post-operative Pain in Colorectal Patients[NCT01836614] | Phase 1/Phase 2 | 0 participants (Actual) | Interventional | 2015-01-31 | Withdrawn (stopped due to Study was closed due to recommendations of performing a PK study first.) | ||
Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Prilocaine Versus Lidocaine[NCT01402869] | 91 participants (Actual) | Interventional | 2011-08-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Change in percentage of methemoglobin in blood from baseline level to peak level (NCT01402869)
Timeframe: From administration of local anesthetic or start of restorative procedures to time at which maximum methemoglobin blood level was documented during dental treatment for an average of 2 hours
Intervention | percentage of methemoglobin in blood (Mean) |
---|---|
Prilocaine | 2.73 |
Lidocaine | 0.78 |
No Local Anesthetic | 0.76 |
The maximum percentage of methemoglobin in blood (NCT01402869)
Timeframe: Measured at 10 second intervals during dental treatment for an average of 2 hours
Intervention | percentage of methemoglobin in blood (Mean) |
---|---|
Prilocaine | 3.55 |
Lidocaine | 1.63 |
No Local Anesthetic | 1.60 |
The length of time between the administration of local anesthetic (Prilocaine and Lidocaine Groups) or start of restorative dental procedures (No local anesthetic Group) and the time at which the maximum methemoglobin blood level is observed. (NCT01402869)
Timeframe: Measured at 10 second intervals during dental treatment for an average of 2 hours
Intervention | minutes (Mean) |
---|---|
Prilocaine | 62.73 |
Lidocaine | 57.50 |
No Local Anesthetic | 29.50 |
11 reviews available for dapsone and Methemoglobinemia
Article | Year |
---|---|
Dapsone-induced hepatic complications: it's time to think beyond methemoglobinemia.
Topics: Animals; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Dapsone; Dose-Response Relat | 2021 |
A patient with leukaemia turns blue.
Topics: Anti-Infective Agents; Child; Cyanosis; Dapsone; Female; Humans; Methemoglobinemia; Neutropenia; Pre | 2009 |
Dapsone-induced methemoglobinemia: a primer for clinicians.
Topics: Anemia, Hemolytic; Anti-Infective Agents; Dapsone; Enzyme Inhibitors; Humans; Methemoglobinemia; Met | 2011 |
Dapsone in the management of autoimmune bullous diseases.
Topics: Agranulocytosis; Animals; Autoimmune Diseases; Dapsone; Disease Management; Drug Hypersensitivity; H | 2012 |
[Side effects of treatment with sulfones].
Topics: Adult; Agranulocytosis; Chemical and Drug Induced Liver Injury; Child; Dapsone; Drug Eruptions; Drug | 1981 |
Sulfonamides and sulfones in dermatologic therapy.
Topics: Animals; Chancroid; Conjunctivitis, Inclusion; Dapsone; Dermatitis Herpetiformis; Erythrocytes; Gluc | 1981 |
Dapsone toxicity: some current perspectives.
Topics: Agranulocytosis; Anti-Infective Agents; Dapsone; Humans; Liver; Methemoglobinemia | 1995 |
Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: a two-case report and review.
Topics: Aged; Dapsone; Female; Humans; Kidney Transplantation; Liver Transplantation; Methemoglobinemia; Mid | 1997 |
Dapsone-induced methemoglobinemia.
Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Dapsone; Female; Humans; Methemoglobinemia; Pne | 1998 |
Methaemoglobinaemia and poisoning.
Topics: Adult; Child, Preschool; Chlorates; Cyanosis; Dapsone; Emergency Medical Services; Emergency Nursing | 2001 |
Adverse effects of dapsone.
Topics: Agranulocytosis; Anemia, Hemolytic; Dapsone; Erythrocytes; Humans; Leukocytes; Leukopenia; Methemogl | 1975 |
3 trials available for dapsone and Methemoglobinemia
Article | Year |
---|---|
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Contraindications; Dan | 2012 |
Dapsone induced methemoglobinemia : Intermittent vs continuous intravenous methylene blue therapy.
Topics: Anti-Infective Agents; Child, Preschool; Dapsone; Enzyme Inhibitors; Female; Humans; Infusions, Intr | 2008 |
Diformyl diaminodiphenyl sufone (DFD) as an antimalarial in man.
Topics: Adult; Antimalarials; Chloroquine; Clinical Trials as Topic; Dapsone; Formates; Humans; Malaria; Mal | 1970 |
173 other studies available for dapsone and Methemoglobinemia
Article | Year |
---|---|
Methaemoglobinaemia in the perioperative period with regional block.
Topics: Benzocaine; Dapsone; Humans; Methemoglobin; Methemoglobinemia; Perioperative Period | 2021 |
A Transplant Patient with Blue Lips, Tongue, and Fingertips.
Topics: Dapsone; Humans; Lip; Methemoglobinemia; Tongue | 2021 |
Three doses of dapsone causing methemoglobinemia in leprosy: A report of two cases.
Topics: Dapsone; Humans; Leprostatic Agents; Leprosy; Methemoglobinemia | 2022 |
Methemoglobinemia in a 28-year-old woman treated with dapsone.
Topics: Adult; Dapsone; Female; Humans; Methemoglobinemia | 2022 |
Dapsone for Refractory Gastrointestinal Symptoms in Children With Immunoglobulin A Vasculitis.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Child; Dapsone; Gastrointestinal Diseases; Humans; IgA Vasc | 2022 |
Dapsone-induced methaemoglobinaemia in relapsing polychondritis.
Topics: Dapsone; Humans; Methemoglobinemia; Polychondritis, Relapsing | 2022 |
Intentional dapsone overdose: a rare cause of acquired methaemoglobinaemia in the emergency department.
Topics: Anti-Infective Agents; Charcoal; Dapsone; Drug Overdose; Emergency Service, Hospital; Female; Humans | 2022 |
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur | 2022 |
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur | 2022 |
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur | 2022 |
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur | 2022 |
Acute dapsone poisoning with methemoglobinemia: a case report.
Topics: Adolescent; Ascorbic Acid; Charcoal; Dapsone; Female; Humans; Methemoglobinemia; Tachypnea | 2022 |
Acute dapsone poisoning with methemoglobinemia: a case report.
Topics: Adolescent; Ascorbic Acid; Charcoal; Dapsone; Female; Humans; Methemoglobinemia; Tachypnea | 2022 |
Acute dapsone poisoning with methemoglobinemia: a case report.
Topics: Adolescent; Ascorbic Acid; Charcoal; Dapsone; Female; Humans; Methemoglobinemia; Tachypnea | 2022 |
Acute dapsone poisoning with methemoglobinemia: a case report.
Topics: Adolescent; Ascorbic Acid; Charcoal; Dapsone; Female; Humans; Methemoglobinemia; Tachypnea | 2022 |
Bad luck comes in threes.
Topics: Anemia, Hemolytic; Dapsone; Humans; Methemoglobinemia; Pneumonia, Pneumocystis | 2023 |
Dapsone Induced Methaemoglobinaemia A reminder the iatrogenic causes of cyanosis.
Topics: Cyanosis; Dapsone; Humans; Iatrogenic Disease; Methemoglobinemia | 2023 |
Severe methemoglobinemia due to topical dapsone misuse in a teenage girl.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Anti-Infective Agents; Dapsone; Drug Misuse; Fem | 2020 |
Methemoglobinemia in Transplant Recipient Patients: Future of Dapsone as
Topics: Anti-Infective Agents; Dapsone; Humans; Methemoglobinemia; Organ Transplantation; Pneumocystis carin | 2020 |
Murphy's law in force: sequential adverse events encountered during the treatment of Pneumocystis pneumonia (cotrimoxazole-induced acute peripheral neuropathy and primaquine-induced methemoglobinemia).
Topics: Anti-Bacterial Agents; Antimalarials; Clindamycin; Dapsone; Drug Therapy, Combination; Female; Human | 2020 |
Closing the saturation gap: a ten-year retrospective experience with methemoglobinemia.
Topics: Adult; Aged; Antimalarials; Cyanosis; Dapsone; Dyspnea; Female; Humans; Infant, Newborn; Male; Massa | 2020 |
27-Year-Old Woman With Fever, Headache, and Anemia.
Topics: Adult; Anemia; Anti-Infective Agents; Blood Gas Analysis; Dapsone; Female; Fever; Headache; Humans; | 2020 |
Whole bowel irrigation in dapsone intoxication with persistent methemoglobinemia.
Topics: Adolescent; Dapsone; Female; Gastrointestinal Tract; Humans; Methemoglobinemia; Methylene Blue; Ther | 2020 |
Subtle case of dapsone-induced methaemoglobinaemia.
Topics: Aged; Anti-Infective Agents; Confusion; Dapsone; Female; Humans; Memory Disorders; Methemoglobin; Me | 2020 |
A case of dapsone-induced methaemoglobinaemia.
Topics: Dapsone; Humans; Methemoglobinemia; Methylene Blue | 2020 |
Symptomatic rebound methaemoglobinaemia after treatment with dapsone.
Topics: Adult; Dapsone; Female; Folic Acid Antagonists; Humans; Methemoglobinemia; Methylene Blue | 2020 |
Dapsone-induced methemoglobinemia in pediatrics post-renal transplant.
Topics: Anti-Infective Agents; Child; Dapsone; Female; Humans; Kidney Transplantation; Male; Methemoglobinem | 2021 |
Unusual cause of persistent dyspnea in a patient with nephrotic syndrome: dapsone-induced methemoglobinemia.
Topics: Aged, 80 and over; Dapsone; Dyspnea; Female; Humans; Methemoglobinemia; Nephrotic Syndrome | 2021 |
Chronic dapsone use causing methemoglobinemia with oxidative hemolysis and dyserythropoiesis.
Topics: Aged, 80 and over; Anti-Infective Agents; Dapsone; Erythrocytes; Erythropoiesis; Female; Folic Acid | 2021 |
A Case of Dapsone-induced Mild Methemoglobinemia with Dyspnea and Cyanosis.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Cyanosis; Dapsone; Dyspnea; Humans; Male; Methemoglobin | 2020 |
[Methemoglobinemia caused by dapsone. Report of one case].
Topics: Dapsone; Female; Humans; Methemoglobinemia; Middle Aged; Rituximab; Trimethoprim, Sulfamethoxazole D | 2020 |
Dapsone-induced methaemoglobinaemia in leprosy: a close mimic of 'happy hypoxia' in the COVID-19 pandemic.
Topics: COVID-19; Dapsone; Humans; Hypoxia; Leprosy; Methemoglobinemia; Pandemics; SARS-CoV-2 | 2021 |
Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction.
Topics: Adult; Anemia, Hemolytic; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Le | 2021 |
Case 5: Fever and Hypoxia in a 17-year-old Boy Undergoing Cancer Chemotherapy.
Topics: Adolescent; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Dapsone; Fever; H | 2017 |
Upward trend of dapsone-induced methemoglobinemia in renal transplant community
.
Topics: Adult; Aged; Anti-Infective Agents; Dapsone; Female; Humans; Kidney Transplantation; Male; Methemogl | 2017 |
Dapsone: An Update.
Topics: Agranulocytosis; Dapsone; Drug Hypersensitivity Syndrome; Humans; Leprostatic Agents; Leprosy; Methe | 2016 |
Methemoglobinemia: A Girl with 'Chocolate Brown' Colored Blood.
Topics: Blood; Child, Preschool; Color; Dapsone; Drug Overdose; Female; Humans; Methemoglobinemia | 2018 |
[Methemoglobinemia due to Dapsone: a pediatric case report].
Topics: Child; Cyanosis; Dapsone; Enzyme Inhibitors; Female; Humans; Methemoglobinemia; Methylene Blue | 2018 |
Methemoglobinemia as a biomarker of dapsone-induced mania severity.
Topics: Biomarkers; Bipolar Disorder; Dapsone; Humans; Male; Methemoglobinemia; Middle Aged | 2019 |
Neutropenia, Hypoxia, and the Complexities of Emergency Medicine: A Case of Dapsone-Induced Methemoglobinemia.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Dapsone; Emergency Service, Hospital; Enz | 2019 |
Dapsone-Induced Methemoglobinemia in Two Renal Transplant Recipients.
Topics: Aged; Anti-Infective Agents; Dapsone; Enzyme Inhibitors; Female; Humans; Kidney Failure, Chronic; Ki | 2019 |
An unusual cause of cyanosis in a patient with COPD.
Topics: Anti-Infective Agents; Cyanosis; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Humans; | 2013 |
Dapsone-induced methemoglobinemia: case of the blue lady.
Topics: Anti-Infective Agents; Dapsone; Female; Humans; Methemoglobinemia; Middle Aged | 2013 |
Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought.
Topics: Adult; Aged; Anti-Infective Agents; Azathioprine; Cohort Studies; Cyclosporine; Dapsone; Female; Glo | 2014 |
Very late recovery of dapsone-induced methemoglobinemia.
Topics: Antidotes; Charcoal; Dapsone; Enterohepatic Circulation; Female; Folic Acid Antagonists; Half-Life; | 2014 |
High-dose vitamin C management in dapsone-induced methemoglobinemia.
Topics: Aged, 80 and over; Ascorbic Acid; Dapsone; Female; Humans; Methemoglobin; Methemoglobinemia; Vitamin | 2014 |
[Dapsone-induced methaemoglobinaemia].
Topics: Dapsone; Enzyme Inhibitors; Female; Folic Acid Antagonists; Humans; Methemoglobinemia; Methylene Blu | 2013 |
Dapsone-induced methemoglobinemia: therapeutic alternatives and medicolegal aspects.
Topics: Ascorbic Acid; Dapsone; Female; Humans; Methemoglobinemia; Vitamins | 2014 |
An audit of dapsone-associated methaemoglobinaemia in renal transplant recipients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dapsone; Female; Humans; Kidney Transplantati | 2014 |
Methemoglobinemia as a complication of topical dapsone.
Topics: Dapsone; Female; Humans; Methemoglobinemia | 2015 |
Methemoglobinemia as a complication of topical dapsone.
Topics: Administration, Topical; Dapsone; Female; Humans; Methemoglobinemia; Young Adult | 2015 |
Acute visual loss following dapsone-induced methemoglobinemia and hemolysis.
Topics: Acute Disease; Adult; Dapsone; Drug Overdose; Female; Hemolysis; Humans; Ischemia; Methemoglobinemia | 2015 |
Identifying the Cause of the "Saturation Gap": Two Cases of Dapsone-induced Methemoglobinemia.
Topics: Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Cryptogenic Organizing Pneumonia; | 2015 |
In Vitro Protective Effect and Antioxidant Mechanism of Resveratrol Induced by Dapsone Hydroxylamine in Human Cells.
Topics: Adult; Antioxidants; Catalase; Cells, Cultured; Dapsone; Erythrocytes; Female; Humans; Male; Methemo | 2015 |
Case Report of Methemoglobinemia in a Toddler Secondary to Topical Dapsone Exposure.
Topics: Administration, Topical; Dapsone; Dermatologic Agents; Female; Humans; Infant; Methemoglobinemia | 2016 |
Difference of the clinical course and outcome between dapsone-induced methemoglobinemia and other toxic-agent-induced methemoglobinemia.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Dapsone; Dose-Response Relationship, Drug; Dru | 2016 |
Extracorporeal treatments in a dapsone overdose: a case report.
Topics: Antidotes; Dapsone; Drug Overdose; Female; Half-Life; Hemofiltration; Hemoperfusion; Humans; Methemo | 2016 |
A case of dapsone induced methaemoglobinaemia.
Topics: Adult; Dapsone; Enzyme Inhibitors; Female; Humans; Methemoglobinemia; Methylene Blue; Oxygen Inhalat | 2008 |
The effect of ethyl pyruvate on dapsone-induced methemoglobinemia in rats.
Topics: Animals; Anti-Infective Agents; Antioxidants; Dapsone; Free Radical Scavengers; Injections, Intraper | 2008 |
Dapsone induced methemoglobinemia in a patient with glioblastoma.
Topics: Anti-Infective Agents; Brain Stem Neoplasms; Dapsone; Glioblastoma; Humans; Male; Methemoglobinemia; | 2009 |
Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia.
Topics: Aged; Anti-Allergic Agents; Dapsone; Dermatitis, Contact; Diphenhydramine; Female; Histamine H1 Anta | 2010 |
Very late relapse of dapsone-induced methaemoglobinemia.
Topics: Adult; Anti-Bacterial Agents; Dapsone; Dermatitis; Female; Humans; Immunosuppressive Agents; Lupus E | 2010 |
Dapsone intoxication: clinical course and characteristics.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Dapsone; Emergency Service, Hospital; Female; Humans; M | 2010 |
The case/ cyanosis in a hemodialysis patient.
Topics: Adult; Anti-Infective Agents; Cyanosis; Dapsone; Female; Humans; Methemoglobinemia; Renal Dialysis; | 2010 |
Acute methaemoglobinaemia secondary to intentional dapsone overdose.
Topics: Acute Disease; Adult; Anti-Infective Agents; Dapsone; Female; Humans; Methemoglobinemia; Methylene B | 2010 |
Dapsone-associated methaemoglobinaemia in patients with a haematologic malignancy.
Topics: Adult; Aged; Anti-Infective Agents; Dapsone; Female; Hematologic Neoplasms; Humans; Male; Methemoglo | 2010 |
Dapsone-induced methemoglobinemia: a dose-related occurrence?
Topics: Anemia, Aplastic; Anti-Infective Agents; Child; Child, Preschool; Cohort Studies; Cross-Sectional St | 2011 |
Case records of the Massachusetts General Hospital: Case 7-2011: a 52-year-old man with upper respiratory symptoms and low oxygen saturation levels.
Topics: Celiac Disease; Cough; Dapsone; Dermatitis Herpetiformis; Diabetes Mellitus, Type 1; Diagnosis, Diff | 2011 |
Dapsone-associated methemoglobinemia in a patient with slow NAT2*5B haplotype and impaired cytochrome b5 reductase activity.
Topics: Aged; Anti-Infective Agents; Arylamine N-Acetyltransferase; Cytochrome P-450 CYP2C19; Cytochrome-B(5 | 2012 |
Curcumin could prevent methemoglobinemia induced by dapsone in rats.
Topics: Animals; Antioxidants; Curcumin; Dapsone; Dose-Response Relationship, Drug; Injections, Intraperiton | 2011 |
Case files of the medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ: methemoglobinemia following dapsone exposure.
Topics: Anti-Infective Agents; Arizona; Cyanosis; Dapsone; Female; Humans; Infant; Infusions, Intravenous; M | 2011 |
Acute dapsone overdose: the effects of continuous veno-venous haemofiltration on the elimination of dapsone.
Topics: Acidosis, Lactic; Adolescent; Anti-Infective Agents; Antidotes; Antioxidants; Ascorbic Acid; Blood G | 2011 |
Unexplained hypoxemia.
Topics: Ascorbic Acid; Azathioprine; Blood Gas Analysis; Dapsone; Female; Follow-Up Studies; Humans; Hyperca | 2011 |
[Lip cyanosis in dapsone therapy: should the dosage be reduced?].
Topics: Cyanosis; Dapsone; Dose-Response Relationship, Drug; Female; Folic Acid Antagonists; Glucosephosphat | 2012 |
Two cases of acquired methemoglobinemia.
Topics: Anti-Infective Agents; Antidotes; Dapsone; Female; HIV Infections; HIV-1; Humans; Male; Methemoglobi | 2012 |
Dapsone use in Loxosceles reclusa envenomation: is there an indication?
Topics: Adult; Anti-Infective Agents; Dapsone; Humans; Male; Methemoglobinemia; Phosphoric Diester Hydrolase | 2003 |
Anesthetic management of a patient with methemoglobinemia.
Topics: Anesthesia; Anti-Inflammatory Agents, Non-Steroidal; Arthroscopy; Dapsone; Female; Humans; Intraoper | 2003 |
Drug-induced methaemoglobinaemia presenting with angina following the use of dapsone.
Topics: Aged; Angina Pectoris; Dapsone; Humans; Male; Methemoglobinemia; Methylene Blue | 2003 |
An unusual complication associated with dapsone therapy of dermatitis herpetiformis.
Topics: Dapsone; Dermatitis Herpetiformis; Humans; Methemoglobinemia; Sulfones | 1958 |
METHEMOGLOBINEMIA ASSOCIATED WITH THE INGESTION OF DIASONE.
Topics: Dapsone; Dermatitis Herpetiformis; Drug Therapy; Humans; Methemoglobinemia; Sulfanilamide; Sulfanila | 1965 |
The tale of a blue toddler.
Topics: Anti-Infective Agents; Child, Preschool; Cyanosis; Dapsone; Enzyme Inhibitors; Humans; Male; Methemo | 2003 |
Methaemoglobinaemia at endoscopy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Endoscopy, Gastrointestinal; Female; Humans | 2004 |
Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Chi | 2004 |
Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Chi | 2004 |
Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Chi | 2004 |
Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Chi | 2004 |
Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for pneumocystis carinii pneumonia (PCP) prophylaxis: a correlation with cytochrome b5 reductase (Cb5R) enzyme levels.
Topics: Anti-Infective Agents; Case-Control Studies; Child; Child, Preschool; Cytochrome-B(5) Reductase; Dap | 2005 |
Complications related to dapsone use for Pneumocystis jirovecii pneumonia prophylaxis in solid organ transplant recipients.
Topics: Adult; Aged; Anemia, Hemolytic; Anti-Infective Agents; Antibiotic Prophylaxis; Dapsone; Female; Huma | 2005 |
Presentation of dapsone-induced methemoglobinemia in a patient status post small bowel transplant.
Topics: Adolescent; Anesthesia, General; Anti-Infective Agents; Dapsone; Folic Acid Antagonists; Humans; Int | 2005 |
Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation.
Topics: Adult; Anemia, Aplastic; Anti-Infective Agents; Dapsone; Female; Hematopoietic Stem Cell Transplanta | 2006 |
Acute methemoglobinemia following attempted suicide by Dapson.
Topics: Acute Disease; Adolescent; Arteries; Blood Cell Count; Blood Gas Analysis; Dapsone; Female; Hospital | 2006 |
Case of methemoglobinemia.
Topics: Aged; Dapsone; Female; Humans; Methemoglobinemia; Methylene Blue | 2006 |
Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Mur | 2006 |
Methylene blue treatment for methemoglobinemia and subsequent dramatic bispectral index reduction.
Topics: Aged; Dapsone; Electroencephalography; Female; Humans; Methemoglobinemia; Methylene Blue | 2006 |
Severe dapsone hypersensitivity syndrome.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatitis Herpetiformis; Drug Eruptions; D | 2006 |
Drug-induced methaemoglobinaemia following elective coronary artery bypass grafting.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Ascorbic Acid; Coronary Artery Bypass; Dapson | 2007 |
The recognition, physiology, and treatment of medication-induced methemoglobinemia: a case report.
Topics: Anesthesia, General; Dapsone; Female; Humans; Leprostatic Agents; Mandibular Fractures; Methemoglobi | 2007 |
Cimetidine and dapsone-mediated methaemoglobinaemia.
Topics: Anti-Infective Agents; Cimetidine; Dapsone; Histamine H2 Antagonists; Humans; Methemoglobinemia; Pos | 2007 |
Guiding management in perioperative methemoglobinemia.
Topics: Dapsone; Folic Acid Antagonists; Humans; Hypoxia; Intraoperative Complications; Methemoglobinemia; M | 2007 |
Successful treatment of acute dapsone intoxication using charcoal hemoperfusion.
Topics: Acne Vulgaris; Adult; Charcoal; Dapsone; Female; Hemolysis; Hemoperfusion; Humans; Hypoxia; Methemog | 1983 |
NADH-methemoglobin reductase and methemoglobinemia among leprosy patients.
Topics: Adult; Cytochrome-B(5) Reductase; Dapsone; Female; Humans; Leprosy; Male; Methemoglobinemia; NADH, N | 1984 |
[Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica].
Topics: Aged; Anemia, Hemolytic; Dapsone; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Iatrogeni | 1984 |
Dapsone-induced methemoglobinemia and hemolysis in the presence of familial hemoglobinopathy Hasharon and familial methemoglobin reductase deficiency.
Topics: Adult; Cytochrome-B(5) Reductase; Dapsone; Hemoglobinopathies; Hemoglobins, Abnormal; Hemolysis; Hum | 1981 |
Delayed sulfhemoglobinemia after acute dapsone intoxication.
Topics: Adult; Dapsone; Humans; Male; Methemoglobinemia; Methylene Blue; Suicide, Attempted; Sulfhemoglobine | 1982 |
[Methemoglobinemia and hemolytic anemia induced by Disulon].
Topics: Acetylation; Anemia, Hemolytic; Dapsone; Humans; Methemoglobinemia; Phenotype; Time Factors | 1982 |
Methemoglobinemia following dapsone ingestion.
Topics: Child; Dapsone; Female; Humans; Methemoglobinemia | 1981 |
Dapsone poisoning (a case report).
Topics: Adolescent; Athetosis; Cyanosis; Dapsone; Humans; Leprosy; Male; Methemoglobinemia | 1981 |
Permanent retinal damage following massive dapsone overdose.
Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic; Dapsone; Fluorescein Angiography; Humans; Macula Lute | 1980 |
Dapsone-induced methemoglobinemia: an anesthetic risk.
Topics: Adolescent; Anesthesia, General; Dapsone; Female; Humans; Lupus Erythematosus, Discoid; Methemoglobi | 1995 |
Severe accidental dapsone overdose.
Topics: Charcoal; Cyanosis; Dapsone; Dermatitis Herpetiformis; Drug Overdose; Humans; Male; Methemoglobinemi | 1995 |
A case of atypical cyanosis.
Topics: Adult; Cyanosis; Dapsone; Humans; Male; Methemoglobinemia; Pneumonia, Pneumocystis | 1995 |
Accidental dapsone poisoning in children.
Topics: Accidents, Home; Ascorbic Acid; Central Nervous System; Child, Preschool; Dapsone; Humans; Male; Met | 1994 |
Chronic methemoglobinemia: improving hemoglobin saturation monitoring during anesthesia.
Topics: Aged; Anesthesia; Cataract Extraction; Chronic Disease; Dapsone; Hemoglobins; Humans; Intraoperative | 1994 |
Acute dapsone poisoning.
Topics: Acute Disease; Adult; Dapsone; Humans; Leprosy; Male; Methemoglobinemia; Suicide, Attempted; Sulfhem | 1993 |
Dapsone poisoning.
Topics: Adult; Combined Modality Therapy; Cyanosis; Dapsone; Female; Fluid Therapy; Humans; Infusions, Intra | 1993 |
Actionstat. Methemoglobinemia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Dapsone; Emergency Nursing; Humans; Male; Methemoglobinem | 1995 |
Fatal poisoning due to dapsone in a patient with grossly elevated methaemoglobin levels.
Topics: Anti-Infective Agents; Dapsone; Drug Overdose; Fatal Outcome; Female; Humans; Methemoglobinemia; Mid | 1995 |
Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency.
Topics: Adult; Aged; CD4 Lymphocyte Count; Dapsone; Drug Hypersensitivity; Erythrocytes; Glutathione; HIV In | 1996 |
Dapsone- and primaquine-induced methemoglobinemia in HIV-infected individuals.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia, Hemolytic; Anti-Infective Agents; Clindamycin; | 1996 |
Worsening oxygen saturation during treatment with oxidative drugs: a clinical reminder.
Topics: Anti-Infective Agents; Dapsone; Humans; Methemoglobinemia; Oxidation-Reduction; Oxygen; Primaquine | 1996 |
Combined dapsone and clofazimine intoxication.
Topics: Adult; Charcoal; Clofazimine; Dapsone; Drug Overdose; Gastric Lavage; Humans; Leprostatic Agents; Ma | 1996 |
A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite.
Topics: Animals; Cimetidine; Dapsone; Enzyme Inhibitors; Female; Folic Acid Antagonists; Histamine H2 Antago | 1996 |
Dapsone induced methaemoglobinaemia.
Topics: Adult; Dapsone; Female; HIV Seropositivity; Humans; Leprostatic Agents; Male; Methemoglobinemia | 1996 |
Acute dapsone intoxication: a pediatric case report.
Topics: Antimalarials; Charcoal; Child, Preschool; Dapsone; Humans; Male; Methemoglobinemia; Methylene Blue; | 1997 |
Deliberate self-poisoning with dapsone. A case report and summary of relevant pharmacology and treatment.
Topics: Adolescent; Antidotes; Bilirubin; Critical Care; Dapsone; Female; Humans; L-Lactate Dehydrogenase; L | 1997 |
Methodologic problems encountered with cooximetry in methemoglobinemia.
Topics: Adult; Aged; Dapsone; Diagnostic Errors; Female; Humans; Male; Methemoglobin; Methemoglobinemia; Oxi | 1997 |
Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; | 1997 |
Dapsone methaemoglobinaemia.
Topics: Adult; Dapsone; Female; Humans; Methemoglobinemia | 1998 |
Asymptomatic methaemoglobinaemia and its implications.
Topics: Cyanosis; Dapsone; Humans; Intraoperative Complications; Leprostatic Agents; Male; Methemoglobinemia | 1998 |
Neonatal methemoglobinemia due to transplacental transfer of dapsone.
Topics: Dapsone; Diagnosis, Differential; Female; Humans; Infant, Newborn; Leprostatic Agents; Leprosy, Lepr | 1998 |
Lessons to be learned: a case study approach: prolonged methaemoglobinaemia due to inadvertent dapsone poisoning; treatment with methylene blue and exchange transfusion.
Topics: Adult; Antidotes; Baclofen; Dapsone; Exchange Transfusion, Whole Blood; Folic Acid Antagonists; Hemo | 1999 |
A case of methemoglobinemia after ingestion of an aphrodisiac, later proven as dapsone.
Topics: Administration, Oral; Adult; Antidotes; Aphrodisiacs; Cyanosis; Dapsone; Humans; Male; Methemoglobin | 1999 |
Factitious methemoglobinemia.
Topics: Adult; Dapsone; Factitious Disorders; Female; Folic Acid Antagonists; Humans; Methemoglobinemia; Sub | 1999 |
Blue and breathless.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Fatal Outcome; Female; HIV Seropositivity; | 1999 |
Dapsone-induced methhaemoglobinaemia: a source of diagnostic confusion.
Topics: Adolescent; Adult; Dapsone; Diagnosis, Differential; Female; Folic Acid Antagonists; Humans; Male; M | 2000 |
[Methemoglobinemia--causes, diagnosis and treatment].
Topics: Adolescent; Adult; Anti-Infective Agents; Dapsone; Female; Humans; Methemoglobinemia; Methylene Blue | 2000 |
Clinical and laboratory parameters in dapsone acute intoxication.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyanosis; Dapsone; Female; Humans; Infant; Leprostatic A | 2000 |
Unexplained acute severe methaemoglobinaemia in a young adult.
Topics: Acute Disease; Adult; Dapsone; Female; Humans; Leprostatic Agents; Methemoglobinemia | 2001 |
[Respiratory insufficiency caused by dapsone-induced methemoglobinemia].
Topics: Anti-Infective Agents; Dapsone; Diagnosis, Differential; Female; Humans; Legionnaires' Disease; Meth | 2001 |
Immunohematotoxicity studies with combinations of dapsone and zidovudine.
Topics: AIDS-Related Opportunistic Infections; Anemia; Animals; Anti-HIV Agents; Antiprotozoal Agents; Bone | 2001 |
Methemoglobinemia associated with the ingestion of Diasone.
Topics: Dapsone; Dermatitis Herpetiformis; Humans; Male; Methemoglobinemia; Middle Aged | 1965 |
Dapsone-induced methemoglobinemia in leprosy patients.
Topics: Adolescent; Adult; Child; Cytochrome Reductases; Cytochrome-B(5) Reductase; Dapsone; Female; Humans; | 2001 |
Diagnostic confusion caused by dapsone-induced methaemoglobinaemia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Asthma; Dapsone; Diagnosis, Differential; Female; Humans; M | 2001 |
Dapsone-induced cholestasis and impairment of bile salt output in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bile Acids and Salts; Biomarkers; Body Weight; Car | 2002 |
Effects of H(2)-receptor antagonists on dapsone-induced methaemoglobinaemia in rats.
Topics: Animals; Biotransformation; Dapsone; Dose-Response Relationship, Drug; Drug Interactions; Famotidine | 2002 |
Acute dapsone intoxication: a case with prolonged symptoms.
Topics: Acetylation; Biotransformation; Dapsone; Hemolysis; Humans; Male; Methemoglobinemia; Middle Aged; Ti | 1979 |
Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage.
Topics: Anemia, Hemolytic; Dapsone; Dose-Response Relationship, Drug; Glucosephosphate Dehydrogenase; Humans | 1979 |
[Case of iatrogenic methemoglobinemia (due to 4,4-diamino-diphenylsulfone)].
Topics: Dapsone; Dermatitis Herpetiformis; Humans; Male; Methemoglobinemia; Methylene Blue; Middle Aged; Tim | 1979 |
Sulfones and sulfonamides in dermatology today.
Topics: Agranulocytosis; Dapsone; Drug Hypersensitivity; Hemolysis; Humans; Kidney Diseases; Methemoglobinem | 1979 |
Hematologic side-effects of dapsone.
Topics: Adult; Agranulocytosis; Dapsone; Female; Hematologic Diseases; Hematopoietic System; Hemolysis; Huma | 1977 |
High dose dapsone toxicity.
Topics: Aged; Anemia, Hemolytic; Dapsone; Dermatitis Herpetiformis; Female; Foot Diseases; Gangrene; Humans; | 1976 |
Serum hemopexin in patients with dermatitis herpetiformis on dapsone (di(4-aminophenyl)sulphone).
Topics: Adult; Aged; Anemia, Hemolytic; Dapsone; Dermatitis Herpetiformis; Erythrocyte Count; Female; Haptog | 1975 |
Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
Topics: Acetylation; Animals; Cimetidine; Dapsone; Drug Interactions; Half-Life; Male; Methemoglobin; Methem | 1992 |
The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
Topics: Adult; Aged; Aged, 80 and over; Cimetidine; Dapsone; Dermatitis Herpetiformis; Drug Therapy, Combina | 1992 |
Dapsone-induced methemoglobinemia and pulse oximetry.
Topics: Dapsone; Female; Humans; Intraoperative Complications; Methemoglobinemia; Methylene Blue; Middle Age | 1992 |
Dapsone-induced methemoglobinemia and hemolytic anemia.
Topics: Adult; Anemia, Hemolytic; Charcoal; Dapsone; Drug Monitoring; Female; Hemoperfusion; Humans; Methemo | 1992 |
Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administration.
Topics: Animals; Chromatography, High Pressure Liquid; Cimetidine; Dapsone; Hydroxylation; Male; Methemoglob | 1991 |
An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro.
Topics: Adolescent; Animals; Biotransformation; Chromatography, High Pressure Liquid; Dapsone; Erythrocytes; | 1991 |
Respiratory insufficiency from dapsone-induced methemoglobinemia.
Topics: Adult; Dapsone; HIV Infections; Humans; Male; Methemoglobinemia; Opportunistic Infections; Pneumonia | 1991 |
Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
Topics: Animals; Bile; Chromatography, High Pressure Liquid; Cimetidine; Dapsone; Half-Life; Liver; Male; Me | 1990 |
The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
Topics: Adult; Cimetidine; Dapsone; Humans; Hydroxylation; Male; Methemoglobinemia | 1990 |
Inhibition of dapsone-induced methaemoglobinaemia in the rat.
Topics: Animals; Cimetidine; Dapsone; Male; Methemoglobinemia; Piperonyl Butoxide; Rats; Rats, Inbred Strain | 1990 |
Sex-dependent sensitivity to dapsone-induced methaemoglobinaemia in the rat.
Topics: Animals; Dapsone; Female; Humans; Hydroxylation; Male; Methemoglobinemia; Rats; Rats, Inbred Strains | 1990 |
Acute dapsone poisoning.
Topics: Child, Preschool; Dapsone; Developing Countries; Drug Overdose; Humans; India; Male; Methemoglobinem | 1989 |
Dapsone-induced methemoglobinemia in a patient with P. carinii pneumonia and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Humans; Male; Methemoglobinemia; Pneumonia, Pneumocysti | 1987 |
Intraoperative cyanosis: a case of dapsone-induced methaemoglobinaemia.
Topics: Adolescent; Cyanosis; Dapsone; Humans; Intraoperative Complications; Male; Methemoglobinemia | 1987 |
Dapsone and Heinz bodies.
Topics: Anemia; Dapsone; Erythrocyte Count; Heinz Bodies; Humans; Methemoglobinemia | 1985 |
[Toxic methemoglobinemia following the postoperative ingestion of 4,4-diaminodiphenylsulfone (DADPS)--on the differential diagnosis of cyanosis].
Topics: Adult; Cyanosis; Dapsone; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Me | 1985 |
Methemoglobinemia from dapsone therapy for a suspected brown spider bite.
Topics: Adult; Dapsone; Female; Humans; Methemoglobinemia; Spider Bites | 1985 |
Exacerbation of dapsone-induced Heinz body hemolytic anemia following treatment with methylene blue.
Topics: Anemia, Hemolytic; Dapsone; Erythrocytes; Female; Glutathione; Heinz Bodies; Humans; Lupus Erythemat | 1974 |
Biochemical effects of aromatic amines. I. Methaemoglobinaemia, haemolysis and Heinz-body formation induced by 4,4'-diaminodiphenylsulphone.
Topics: Chromatography, Ion Exchange; Cytoplasm; Dapsone; Dermatitis Herpetiformis; Erythrocytes; Heinz Bodi | 1965 |
Microsomal N-oxidation of dapson as a cause of methemoglobin formation in human red cells.
Topics: Animals; Carbon Isotopes; Chromatography, Thin Layer; Dapsone; Erythrocytes; Hemoglobins; Humans; In | 1972 |
Haemolytic effects of DDS in leprosy patients.
Topics: Adult; Anemia, Hemolytic; Dapsone; Erythrocytes; Female; Glucosephosphate Dehydrogenase Deficiency; | 1972 |
[Case of severe poisoning with diamino-diphenylsulfone (DDS)--an antileprotic drug].
Topics: Adolescent; Dapsone; Diuresis; Exchange Transfusion, Whole Blood; Female; Furosemide; Humans; Methem | 1972 |
Polymorphic acetylation of drugs in rabbits.
Topics: Acetylation; Aminobenzoates; Aminosalicylic Acids; Animals; Body Temperature; Chromatography, Thin L | 1973 |
[Glutathione reductase deficiency in Duhring's dermatitis herpetiformis].
Topics: Aged; Blood Cell Count; Child; Clinical Enzyme Tests; Dapsone; Dermatitis Herpetiformis; Erythrocyte | 1973 |
Reduced pressure potentiation of the side effects of the antimalarial, Dapsone.
Topics: Aerospace Medicine; Altitude; Anemia; Animals; Asia, Southeastern; Dapsone; Erythrocyte Count; Hyper | 1967 |
Mechanism of methemoglobin formation by diphenylsulfones. Effect of 4-amino-4'-hydroxyaminodiphenylsulfone and other p-substituted derivatives.
Topics: Azo Compounds; Carbon Isotopes; Dapsone; Erythrocytes; Esters; Hemoglobins; Humans; Infrared Rays; K | 1972 |
Dapsone poisoning.
Topics: Ascorbic Acid; Child, Preschool; Cyanosis; Dapsone; Dyspnea; Female; Heart Rate; Hemoglobins; Humans | 1970 |
Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam.
Topics: Antimalarials; Chloroquine; Cyanosis; Dapsone; Diseases in Twins; Erythrocytes; Female; Hematocrit; | 1968 |
The effects of dapsone on red cells.
Topics: Cell Membrane; Dapsone; Erythrocytes; Female; Humans; Male; Methemoglobinemia | 1968 |
[Hematological changes in acute accidental poisoning with sulfones].
Topics: Anemia, Hemolytic; Blood; Child; Child, Preschool; Dapsone; Female; Glucosephosphate Dehydrogenase; | 1966 |